Zinc Gluconate

Zinc gluconate is elemental zinc bound to gluconic acid — a well-absorbed, inexpensive, widely available salt, and one of the two forms (with zinc acetate) most studied in cold lozenges. It carries roughly 14% elemental zinc by weight, so a meaningful dose means a larger amount of compound than a higher-density form. For zinc’s full, form-agnostic evidence base — including the contested common-cold-duration data — see Zinc; this page covers only what is specific to the gluconate form.

Absorption & Tolerability

In the one direct human isotope-tracer comparison, fractional absorption from zinc gluconate was ~61% (median, taken without food) — statistically indistinguishable from zinc citrate (~61%) and significantly higher than zinc oxide (~50%, with three of fifteen subjects absorbing little or none) ^{1Reference 1Wegmüller R et al. · 2014RCTZinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide — [randomised crossover trial]View study →}. Gluconate is therefore a genuinely well-absorbed form, not merely a marketing claim — the “poorly absorbed” label belongs to oxide, not to gluconate.

Tolerability is generally good. Because elemental density is low (~14%), the tablet or lozenge is physically larger for a given zinc dose, and — as with all zinc salts — nausea is the common acute complaint, worse on an empty stomach and worse still as a slowly-dissolved lozenge that bathes the stomach lining. Taking oral doses with food reduces this at the cost of some absorption.

What the Evidence Says

Gluconate’s form-specific evidence is almost entirely in common-cold lozenges; for zinc’s repletion, growth, diarrhoea, and immune roles see the hub.

• Cold lozenges — the honest read. Gluconate lozenges have produced both clear positive trials and clear nulls, and the split tracks lozenge formulation more than the salt itself. Early positive work (Eby 1984: colds ~7 days shorter) ^{2Reference 2Eby GA et al. · 1984RCTReduction in duration of common colds by zinc gluconate lozenges in a double-blind study — [RCT]View study →} and a widely cited positive trial (Mossad 1996) ^{3Reference 3Mossad SB et al. · 1996RCTZinc gluconate lozenges for treating the common coldView study →} contrast with Turner & Cetnarowski (2000), where gluconate shortened only experimental colds by ~1 day (2.5 vs 3.5 days, P=.035) and did nothing for natural colds, while acetate did nothing at all ^{4Reference 4Turner RB · 2000RCTEffect of treatment with zinc gluconate or zinc acetate on experimental and natural colds — [RCT]View study →}. Much of the variability comes from flavourings and binders (citric acid, sorbitol, mannitol) that bind zinc ions and cut the free Zn²⁺ actually released in the mouth.
• Gluconate vs. acetate. A meta-analysis restricted to lozenge trials dosing >75 mg/day found colds ~33% shorter overall, with acetate trials averaging ~40% and gluconate ~28% — but the difference between the two salts was not statistically significant (12 percentage points, 95% CI −12 to +36) ^{5Reference 5Hemilä H · 2017Meta-analysisZinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage — [meta-analysis]View study →}. The same analysis found no added benefit above ~100 mg/day. In short: a properly composed gluconate lozenge appears about as useful as an acetate one; the choice of salt is not the deciding variable, formulation is.

Bottom line for this form: for cold lozenges, gluconate is a reasonable, evidence-consistent choice provided the lozenge isn’t formulated with zinc-binding sweeteners; for plain daily repletion, gluconate is well-absorbed and inexpensive, and the form matters little.

Dosage

Dosed as elemental zinc, not compound weight — at ~14% elemental, a “50 mg zinc gluconate” tablet supplies only ~7 mg of zinc, so read labels for the elemental figure.

• Daily repletion: intake references are set for elemental zinc — RDA 8–11 mg/day for adults, Tolerable Upper Intake Level 40 mg/day (UL counts supplemental zinc, and it is easy to approach with lozenge protocols). See the Zinc hub for full intake detail.
• Cold lozenges: trials that worked used ≥80 mg/day elemental, in divided lozenges every 2–3 hours from the first symptoms, for no more than about a week. This is a short-term therapeutic pattern that deliberately exceeds the daily UL, not a maintenance dose.

These are doses studied in research, not a personal recommendation.

Safety

General zinc cautions apply and are covered in full on the Zinc hub; two points are form-relevant here:

• Copper depletion. Sustained oral intake at or above ~40 mg/day elemental zinc can induce copper deficiency (anaemia, neutropenia, and — over long periods — neurological signs). Cold-lozenge protocols exceed this but are short; chronic daily high-dose gluconate is the real risk.
• Intranasal gluconate — do not use. Intranasal zinc-gluconate gels and sprays (marketed for colds) are linked to anosmia, sometimes lasting or permanent; the mechanism is direct zinc toxicity to olfactory neurons ^{6Reference 6Hsieh H et al. · 2016In vitroMechanistic studies of the toxicity of zinc gluconate in the olfactory neuronal cell line Odora — [in vitro]View study →}. This risk is specific to the nasal route — oral lozenges and tablets do not carry it. Use gluconate orally only.
• GI upset (nausea) is the common acute effect, worse on an empty stomach and as lozenges; take oral doses with food.

For zinc’s full interaction set — iron, certain antibiotics (tetracyclines/quinolones), penicillamine, all taken separated by 2+ hours — see the Zinc hub; those are form-agnostic and not re-audited here.

Pregnancy & lactation

No gluconate-form-specific pregnancy or lactation data exists; follow the zinc-level guidance on the Zinc hub — the RDA is modestly higher in pregnancy, and the 40 mg/day elemental UL should not be exceeded without clinical advice.

Related compounds / cross-links

• Zinc — the form-agnostic hub: full evidence base, intake references, and complete safety/interaction detail.
• Zinc acetate — the other principal cold-lozenge salt; comparable efficacy when properly formulated.
• Zinc oxide — the denser, less-absorbed salt; the “poorly absorbed” contrast to gluconate.

References